Research article · 31 Jul 2026
PerspectivePublished 30 Jan 2023
Mother to Child Transmission Toxicity and Pharmacotherapy: HIV in Pregnancy
Department of Biotechnology, University of Awadh, India
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In 2018, an estimated 1.3 million pregnant women have HIV. All HIV-positive pregnant women, regardless of clinical stage, should take a combination of antiretroviral medications to reduce maternal viral load and avoid vertical foetal infection since HIV infection is linked to worse pregnancy outcomes. Antiretroviral therapy during pregnancy unquestionably reduced mother-to-child HIV transmission, but there are still a few unknowns. For instance, pharmacokinetic parameters alter during pregnancy, yet there is a paucity of pertinent information from clinical research. Similar to this, nothing is known about the long-term negative consequences of antiretroviral exposure on foetuses. Here, we go through the most recent research on HIV's effects on the placenta and growing baby, suggested antiviral dosages, and pharmacokinetic factors with a focus on placental transport.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Pregnancy and Child Health.
Editorial · 22 Jul 2026
Nurturing Development: Key Factors For Child Well-being
Editorial · 20 Jul 2026
Foundations of Healthy Infant Development: A Holistic Approach
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Pregnancy and Child Health
- SubjectPaediatrics & Neonatology
- SubjectReproductive Medicine & Gynaecology
- BylineArticles whose byline prints “Sneha Srivastava”